Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06500143Completed

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

Role: collaborator

NCT04458337Completed

SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)

Role: collaborator

NCT05082337Not ApplicableCompleted

The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures

Role: collaborator

All 3 trials loaded